Immune cells produced during severe COVID-19 infection may shrink tumors. The unexpected mechanism offers a new therapeutic ...

President-elect Donald Trump's return to the White House could mean a push to revoke a federal directive for hospitals to ...

Researchers have tested a novel therapeutic concept to treat virus-induced lung failure in patients with severe COVID-19 in a phase 2 clinical trial. The approach may also be applicable to other ...

About $1.6 billion has been invested in research that has yielded little progress, disappointing many who suffer with the ...

Just as Kennedy championed off-patent drugs like ivermectin and hydroxychloroquine to treat COVID, Laetrile’s defenders ...

There are certain phrases that Wachuka Gichohi finds difficult to hear after enduring four years of living with long COVID, ...

The Centers for Disease Control and Prevention (CDC) has issued new advice regarding vaccines for COVID and pneumonia. The ...

Kennedy Jr. suggested that the COVID-19 virus was engineered to give Chinese and Ashkenazi Jewish people immunity.

The company records direct sales and alliance revenues from its partner, BioNTech BNTX, for the COVID-19 vaccine, Comirnaty, and product revenues from its oral antiviral pill for COVID ...

An experimental COVID-19 treatment pill called Molnupiravir being developed by Merck & Co Inc and Ridgeback Biotherapeutics LP, is seen in this undated handout photo released by Merck & Co Inc and ...